InsidersTradesSigma
Browse the detailed record of transactions filed by DAmour Kevin, Directeur Scientifique. Officer active across 1 companies, notably Brooklyn ImmunoTherapeutics, Inc.. In total, 1 disclosures have been logged. Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
DAmour Kevin is the Chief Scientific Officer at Brooklyn ImmunoTherapeutics, Inc. He is responsible for research and development initiatives, contributing to the innovation and growth of the company.